Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00812552 · ClinicalTrials.gov registry record

Drug Eluting Stent Registry of Thrombosis

A clinical trial of Coronary Artery Disease, sponsored by Medstar Health Research Institute.

Completed
Registry status
984
Enrollment target
20
Study locations

NCT00812552 is a study of Coronary Artery Disease that has completed, run by Medstar Health Research Institute. The registered enrollment target is 984 participants, below the 1,282-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (23% lower). The trial reports 20 study locations across 18 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00812552, a study of Coronary Artery Disease, has completed, sponsored by Medstar Health Research Institute.

COMPLETED
Registry status
984 participants
Enrollment target
20
Study locations

Study Summary

Multicenter, case-control study, to collect data regarding incidences of late and very late drug-eluting stent thrombosis with the aim of identifying trends and possible correlates of stent thrombosis.

Conditions Studied

Study Locations (20)

Massachusetts

  • Beth Israel Deaconess Medical Center - Boston
  • Lahey Clinic - Burlington

New York

  • New York Methodist Hospital - Brooklyn
  • Columbia University Medical Center - New York

California

  • Mercy General Hospital / Mercy Heart and Vascular Institute Cardiovascular Research - Sacramento

District of Columbia

  • Washington Hospital Center - Washington D.C.

Illinois

  • Prairie Education and Research Cooperative - Springfield

Kentucky

  • Lexington Cardiac Research Foundation/Central Baptist Hospital - Lexington

Maine

  • Maine Medical Center - Portland

Maryland

  • Washington Adventist Hospital - Takoma Park

Trial Details

FieldValue
Enrollment Target 984 participants
Start Date 2009-09
Est. Completion 2012-05

Sponsor

Medstar Health Research Institute

115 total trials

What the Registry Record Tells You About NCT00812552

The ClinicalTrials.gov registry entry for NCT00812552 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 984 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,282-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (23% lower). The listed sponsor is Medstar Health Research Institute, which has 115 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Coronary Artery Disease appearing as the primary indexed condition, and to 0 interventions.

NCT00812552 reports 20 study locations spanning 18 distinct geographic areas - top geographies include Massachusetts, New York, California.

Frequently Asked Questions

What is clinical trial NCT00812552 about?

NCT00812552 is a clinical study titled "Drug Eluting Stent Registry of Thrombosis". Multicenter, case-control study, to collect data regarding incidences of late and very late drug-eluting stent thrombosis with the aim of identifying trends and possible correlates of stent thrombosis.

What is the current status of trial NCT00812552?

This trial is currently completed. The enrollment target is 984 participants. The study started on 2009-09. Estimated completion is 2012-05.

What conditions does trial NCT00812552 study?

This clinical trial studies the following conditions: Coronary Artery Disease.

Who is sponsoring clinical trial NCT00812552?

This trial is sponsored by Medstar Health Research Institute, which has 115 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00812552 being conducted?

This trial has 20 study locations across California, District of Columbia, Illinois, Kentucky, Maine. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Coronary Artery Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.